Ni Jun

8PUBLICATIONS
15CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 12, 2025
Chinese Expert Consensus on the Diagnosis and Treatment of Inflammatory Myofibroblastic Tumor.

Xiaoyan Si, Shafei Wu, Rui'e Feng

|Feb 12, 2022
Second primary tumor after immune checkpoint inhibitor therapy: A case report.

Kang Miao, Shuangni Yu, Jun Ni

|Dec 31, 2021
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.

Jun Ni, Xiaotong Zhang, Hanping Wang

|Mar 03, 2021
Non-small-cell lung cancer with ERBB2 mutation in non-tyrosine kinase domain benefits from pyrotinib: A case report.

Jun Ni, Xiao-Yan Si, Li Zhang

|May 28, 2020
Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non-small-cell lung cancer and ERBB2 mutation.

Yanyan Wu, Jun Ni, Xiaoyan Chang

|May 15, 2020
Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study.

Ni Jun, Wang Hanping, Si Xiaoyan

Pageof 2

Frequent Collaborators

5 joint publications

Xiaoyan Si

5 joint publications

Zhang Xiaotong

4 joint publications

Li Zhang

3 joint publications

Yan Xu